News Announcement

Advanced Enzyme Technologies: Outcome Of Board Meeting Held On February 06 2020

With reference to the Board meeting notice dated January 24 2020 we hereby inform that the Board of Directors in its meeting held on February 06 2020 (commenced at 12.35 p.m. and concluded at 1.05 p.m.) has inter-alia transacted the following business:

1. Approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31 2019
2. Allotted 2 000 equity shares of face value of Rs. 2/- at an exercise price of Rs. 60 per share pursuant to exercise of options by the eligible employees under the Companys Employees Stock Option Scheme 2015.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.